COMMUNIQUÉS West-GlobeNewswire

MPX Bioceutical Corporation to Host Investor Conference Call on June 12, 2018
07/06/2018
TORONTO, June 07, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) today announced that it will hold a conference call to update investors on the recently completed US$40 million convertible [...]
Trillium Therapeutics Appoints Yaping Shou, MD, PhD as Chief Medical Officer
07/06/2018
TORONTO, June 07, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today the [...]
FibroGen Announces Completion of Enrollment in U.S. Phase 3 Clinical Program for Roxadustat in Anemia Associated with Chronic Kidney Disease
07/06/2018
SAN FRANCISCO, June 07, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN), a biopharmaceutical company, today announced the completion of patient enrollment in the Phase 3 studies supporting the U.S. new drug [...]
Resverlogix Highlights Potential to Develop Apabetalone as a Therapeutic for HIV-1 Eradication Utilizing the “Shock and Kill” Approach
07/06/2018
Based on a growing body of data demonstrating apabetalone’s beneficial attributes as a latency-reversing agent for advancing HIV-1 eradication, Resverlogix is seeking a partner for future development CALGARY, Alberta [...]
Sandoz Canada launches (Pr)Sandoz Levetiracetam® 1000 mg tablets as an adjunctive treatment of epilepsy
07/06/2018
Sandoz Canada is the first company in Canada to offer levetiracetam in the higher concentration 1000 mg, enabling patients to reduce the number of tablets they need to take daily. Pr Sandoz Levetiracetam ® is indicated [...]
Sandoz Canada lance (Pr)Sandoz Levetiracetam® en comprimés de 1 000 mg pour le traitement adjuvant de l’épilepsie
07/06/2018
Sandoz Canada est la première entreprise au Canada à offrir le lévétiracétam dans une concentration de 1 000 mg, ce qui permet aux patients de réduire le nombre de comprimés à prendre quotidiennement. Pr Sandoz [...]
Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service
07/06/2018
Joint offering enables acceleration of genomic panel design for translational and clinical disease research SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation announced today that it has [...]
Emergent BioSolutions Announces $50 Million Expansion of Baltimore Fill/Finish Facility
07/06/2018
Multi-year investment will support growth of contract development and manufacturing capabilities GAITHERSBURG, Md., June 07, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the beginning [...]
Bavarian Nordic A/S - Articles of Association
07/06/2018
Updated Articles of Association for Bavarian Nordic A/S Attachment BavarianNordicArticlesofAssociation.pdf
Athersys Announces Expansion of Collaboration With Healios
07/06/2018
Healios receives rights to develop and commercialize additional indications and Athersys receives $20 million in license fees, plus potential milestones payments and royalties Discussions extended for China and other [...]
PotNetwork Holdings’ Diamond CBD’s Meds Biotech Line Expands With Heighted Demand for Its New CBD and “CBD & Tumeric” Supplements
07/06/2018
Company’s Expansion Into Health-Focused Industry Sector Gains Momentum FT LAUDERDALE, Fla., June 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- PotNetwork Holding Inc. (the “Company”), (OTC Pink:POTN) is pleased to [...]
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
07/06/2018
COPENHAGEN, Denmark, June 7, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company's share capital has been increased by nominally DKK 655,000 as a consequence of employees' exercise of [...]
Genetic Technologies Announces Binding Project Shivom Agreement
07/06/2018
MELBOURNE, Australia, June 07, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE), “ Company ”, “ GTG ”), a diversified molecular diagnostics company embracing blockchain technologies across [...]
Hope Pharmaceuticals Files Supplemental New Drug Application to the Food and Drug Administration for Sodium Thiosulfate Injection
07/06/2018
SCOTTSDALE, Ariz., June 07, 2018 (GLOBE NEWSWIRE) -- Hope Pharmaceuticals today announced that the company filed a Supplemental New Drug Application to the United States Food and Drug Administration (FDA) for the use of [...]
Amarin Sponsors Three Scientific Presentations Scheduled for American Diabetes Association Scientific Sessions
07/06/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, June 07, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Enzymatica AB: Enzymatica secures funding for operations
07/06/2018
Press release June 7, 2018 Enzymatica secures funding for operations Enzymatica has received a bridge loan of total SEK 30 million from three of its principle owners to fund the business for 2018. At the same time, the [...]
LIDDS: Major European Investment Funds invest 21,7 MSEK in a direct share issue
07/06/2018
LIDDS AB (publ) has decided on a direct share issue to Nyenburgh Holding BV, AESCAP 2.0 and BWG Invest, all being international funds that invests in closely selected European biotech- and pharma companies. The raised [...]
VALNEVA Announces the Availability of Documentation for its Meeting of Shareholders
07/06/2018
Valneva Announces the Availability of Documentation for its Meeting of Shareholders Lyon (France), June 7, 2018 - The Shareholders of Valneva SE ("Valneva" or "the Company") are invited to participate in the Company's [...]
VALNEVA annonce la mise à disposition des documents préparatoires à l'Assemblée d'actionnaires
07/06/2018
Valneva annonce la mise à disposition des documents préparatoires à l'Assemblée d'actionnaires Lyon (France), 7 juin 2018 - Les actionnaires de la société Valneva SE (ci-après "Valneva" ou "la Société") sont invités à [...]

Pages